Advent France Biotechnology has held a first close for its maiden life sciences seed fund, Advent France Biotechnology Seed Fund I, with €64.75m of commitments.
Deal marks the first acquisition for the GP's latest vehicle, Alto Capital IV
Second bolt-on completed by Valco since Argos Soditic became majority shareholder in 2014
Asset management business will look to expand its regional network and make bolt-on acquisitions
Firm plans to expand domestically and internationally, primarily in Asia